Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. 

Biotechnology

Sigilon Therapeutics

Sigilon Therapeutics' headquarters in Cambridge, MA, United States

Rogerio Vivaldi

Joseph Tumang

Jiang Wu

Olivia G. Kelly

Omid Veiseh

Jamie M.

Jamie Murphy

Sarah Yuan

Ulrik B. Nielsen

Robert Langer

Arturo Vegas

Michael Rosenblatt

Constance Cepko

Daniel G. Anderson

José Oberholzer

The Leadership Team at Sigilon Therapeutics is responsible for setting the strategic direction of the company and overseeing the development of innovative therapies aimed at restoring normal physiology through engineered human cells. Comprising industry veterans and founders, the team collaborates to drive research efforts, ensure regulatory compliance, and navigate the complexities of bringing cutting-edge treatments from concept to clinical application, ultimately striving to improve patient outcomes in chronic disease management.

Leadership Team

The Administration and Executive Management team at Sigilon Therapeutics is responsible for setting the strategic direction, overseeing company operations, leading scientific research initiatives, and ensuring organizational growth and innovation. Comprised of top executives and key leaders, this team focuses on aligning efforts across departments to advance the development of immune-protected engineered human cells and drive the company's mission forward.

Administration and Executive Management

The Scientific and Research Team at Sigilon Therapeutics focuses on developing and optimizing immune-protected, engineered human cells to restore normal physiological functions in a variety of chronic diseases. This team conducts cutting-edge research, develops bioanalytical assays, manages preclinical studies, and ensures efficient lab operations to advance Sigilon's innovative cell therapies from discovery through development stages.

Scientific and Research Team

The Advisors Team at Sigilon Therapeutics provides strategic guidance and expert insights to support the development and implementation of innovative therapies involving immune-protected, engineered human cells. Their expertise helps navigate scientific, clinical, and regulatory challenges to further the company's mission of treating serious chronic diseases.

Advisors Team

The Finance and Quality Team at Sigilon Therapeutics oversees financial management, budgeting, and accounting, while also ensuring that the company’s engineered human cell products adhere to the highest quality standards through rigorous validation processes and compliance with regulatory requirements.

Sigilon Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Administration and Executive Management

Scientific and Research Team

Advisors Team

Finance and Quality Team

Offices

Sigilon Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Administration and Executive Management

Scientific and Research Team

Advisors Team

Finance and Quality Team

Offices

Related companies